Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
Holding SLNO?
Track your performance easily

Soleno Therapeutics (SLNO) Ownership - Who Owns Soleno Therapeutics?

707 Followers

Soleno Therapeutics (SLNO) Ownership Overview

19.72%9.75%0.03%9.35%61.15%
19.72% Insiders
0.03% Other Institutional Investors
9.35% ETFs
61.15% Public Companies and
Individual Investors
The ownership structure of Soleno Therapeutics (SLNO) stock is a mix of institutional, retail, and individual investors. Approximately 19.12% of the company’s stock is owned by Institutional Investors, 19.72% is owned by Insiders, and 61.15% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 03, 2024
Patricia C Hirano
Svp, Regulatory Affairs
xxxxxxxxxxxxx
$153608
Oct 03, 2024
Anish Bhatnagar
Ceo,director
xxxxxxxxxxxxx
$1069176
Oct 03, 2024
Kristen Yen
Svp, Clinical Operations
xxxxxxxxxxxxx
$153608
Oct 03, 2024
xxxxxxxxxxxxx
$399193

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$4488000
Jun 30, 2024
xxxxxxxxxxxxx
$5920488
Jun 30, 2024
xxxxxxxxxxxxx
$13023564
Jun 30, 2024
xxxxxxxxxxxxx
$130763020

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,291,851Insider16.19%345,548,457
3,204,976Institution8.25%176,017,282
1,483,624Institution3.82%81,480,630
1,255,789Institution3.23%68,967,932
1,241,712Institution3.19%68,194,823
883,826Institution2.27%48,539,724
719,553Insider1.85%39,517,851
633,526Institution1.63%34,793,248
326,143Institution0.84%17,911,774
319,205Institution0.82%17,530,739

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,255,789Institution3.23%68,967,932
1,241,712Institution3.19%68,194,823
234,730Institution0.60%12,891,372
170,500Institution0.44%9,363,860
168,265Institution0.43%9,241,114
151,241Institution0.39%8,306,156
141,888Institution0.37%7,792,489
97,066Institution0.25%5,330,865
71,598Institution0.18%3,932,162
63,203Institution0.16%3,471,109

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
913,592Institution2.35%46,127,260
600,767Institution1.55%32,994,124
602,787Institution1.55%31,965,795
364,608Institution0.94%18,409,058
253,312Institution0.65%13,911,895
205,109Institution0.53%11,264,586
115,318Institution0.30%6,115,314
105,752Institution0.27%5,339,418
71,107Institution0.18%3,905,196
61,473Institution0.16%3,103,772

FAQ

Who Owns Soleno Therapeutics Inc (SLNO)?
According to the latest TipRanks data, approximately 0.03% of the company's stock is held by institutional investors, 19.72% is held by insiders, and 61.15% is held by retail investors.
    What percentage of Soleno Therapeutics Inc (SLNO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.03% of Soleno Therapeutics Inc (SLNO) stock is held by institutional investors.
      What percentage of Soleno Therapeutics Inc (SLNO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 61.15% of Soleno Therapeutics Inc (SLNO) stock is held by retail investors.
        Who owns the most shares of Soleno Therapeutics Inc (SLNO)?
        Vivo Opportunity, LLC owns the most shares of Soleno Therapeutics Inc (SLNO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis